Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PROSCA BLADDR 2021 | Social media: curse or blessing in the field of oncology

Gilberto Morgan • 13 Oct 2021
PROSCA BLADDR 2021
General

Gil Morgan, MD, Skåne University Hospital, Lund, Sweden, discusses how social media shapes oncology, and its role in the future. Dr Morgan highlights the OncoAlert netwrk, a network where the oncology society can interact with on another and stay informed on the newest data in the field. This interview took place at the PROSCA/BLADDR 2021 congress.

More from Gilberto Morgan

OncoAlert and ESMO survey – social media & virtual meetings in the COVID-19 era
2:48
OncoAlert and ESMO survey – social media & virtual meetings in the COVID-19 era
Gilberto Morgan • 14 Jul 2020
Social networks in medicine: US to Europe and beyond
1:40
Social networks in medicine: US to Europe and beyond
Gilberto Morgan • 27 Sep 2019
Twitter oncology networks: interview with @weoncologists on the @OncoAlert movement
3:40
Twitter oncology networks: interview with @weoncologists on the @OncoAlert movement
Gilberto Morgan • 28 Sep 2019
Oncology HCPs online: balancing cancer education internationally
1:51
Oncology HCPs online: balancing cancer education internationally
Gilberto Morgan • 28 Sep 2019

Related Videos

PALEM: palliative arterial embolization for painful bone metastases
1:20
PALEM: palliative arterial embolization for painful bone metastases
Yasunori Arai • 26 Oct 2026
The benefits of arterial embolization for palliative pain management
1:21
The benefits of arterial embolization for palliative pain management
Yasunori Arai • 26 Oct 2026
Examining difficulties in patient selection for investigational immunotherapies
1:15
Examining difficulties in patient selection for investigational immunotherapies
Sebastian Kobold • 26 Oct 2026
Learning from early trials of cellular and vaccine-based immunotherapies
1:10
Learning from early trials of cellular and vaccine-based immunotherapies
Sebastian Kobold • 26 Oct 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals